LEUKOCARE AG
Biotechnology, Medical Technology
-
Short facts
-
- Research & Development
- Year founded 2003
- 21 Employees (site)
- Turnover: <5m EUR
Products/services: LEUKOCARE provides a next-generation formulation technology platform for the protection of proteins like biopharmaceuticals to allow the development of better products. The proprietary Stabilizing and Protecting Solutions (SPS®) technologies are provided to development projects of partners in the pharmaceutical and medical device industry. As different stakeholders have different needs, the SPS® platform is separated into the following three main pillars: - improvement of thermal stability - protection during sterilization - functionalization of medical devices LEUKOCARE's SPS® technologies improve stability and quality of biologics like antibodies, vaccines including live viral vectors etc. in dry and liquid formulation and protect proteins in biologically functionalized medical devices like implants, wound dressings, microneedles etc. during sterilization. LEUKOCARE provides a next-generation formulation technology platform for the protection of proteins like biopharmaceuticals to allow the development of better products. The proprietary Stabilizing and Protecting Solutions (SPS®) technologies are provided to development projects of partners in the pharmaceutical and medical device industry. As different stakeholders have different needs, the SPS® platform is separated into the following three main pillars: - improvement of thermal stability - protection during sterilization - functionalization of medical devices LEUKOCARE's SPS® technologies improve stability and quality of… read more
Basic data
Company
LEUKOCARE AG
Street
Am Klopferspitz 19
PC / City
82152 Planegg
County
Upper Bavaria
Phone
+498978016650
Fax
+4989780166511
Homepage
Language skills
English, German
Contact person
Management: Michael Scholl (Mr.)
Sales / marketing: Simone Knappmann (Mrs.)
Profile/competences
Core competencies
LEUKOCARE’s research and development activities are based on its well established quality management system (QM) according to EN ISO 9001 and EN ISO 13485. LEUKOCARE's laboratories have permission for Biosafety Level 2.
Key sectors / sub-sectors
- Biotechnology: Animal health
- Biotechnology: Preclinical development
- Biotechnology: Prophylactic drug development
- Biotechnology: Therapeutic drug development
- Medical Technology: Dialysis, apheresis
- Medical Technology: Immunology
- Medical Technology: Implants, biomaterials, tissue engineering
NACE industries
- Scientific research and development 72
- Research and experimental development on natural sciences and engineering 72.1
- Research and experimental development on biotechnology 72.11
Certifications
- DIN EN ISO 9001
- ISO 13485
Sales markets - target industries
not available
Sales markets - target countries
Australia, Austria, Belgium, Canada, China, Denmark, Finland, France, Germany, Iceland, India, Indonesia, Ireland, Italy, Japan, Korea, Republic of, Luxembourg, Netherlands, New Zealand, Norway, Poland, Portugal, Singapore, Spain, Sweden, United Kingdom, United States
Cooperation offers
LEUKOCARE provides a next-generation formulation technology platform for the protection of proteins like biopharmaceuticals to allow the development of better products. LEUKOCARE's SPS® technologies improve stability and quality of biologics like antibodies, vaccines including live viral vectors etc. in dry and liquid formulation and protect proteins in biologically functionalized medical devices like implants, wound dressings, microneedles etc. during sterilization. Beyond, LEUKOCARE supports its partners with related services and know how in order to evaluate and to implement the SPS® technologies and formulations in the partnered products: Development of individual SPS® formulations Development of accelerated aging models Development of customized lyophilization protocols Development of spray drying and spray freeze drying processes Coupling of biological compounds to functionalize surfaces Establishment of biological read outs Capabilities to work with biosafety level 2 material